Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial.
Finkelstein, J S
Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial. [electronic resource] - JAMA - 1067-73 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
0098-7484
10.1001/jama.280.12.1067 doi
Adult
Analysis of Variance
Biomarkers--blood
Blood Chemical Analysis
Bone Density--drug effects
Bone Remodeling
Drug Administration Schedule
Endometriosis--drug therapy
Estrogens--deficiency
Female
Hormones--adverse effects
Humans
Nafarelin--adverse effects
Osteoporosis--etiology
Teriparatide--administration & dosage
Urinalysis
Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial. [electronic resource] - JAMA - 1067-73 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
0098-7484
10.1001/jama.280.12.1067 doi
Adult
Analysis of Variance
Biomarkers--blood
Blood Chemical Analysis
Bone Density--drug effects
Bone Remodeling
Drug Administration Schedule
Endometriosis--drug therapy
Estrogens--deficiency
Female
Hormones--adverse effects
Humans
Nafarelin--adverse effects
Osteoporosis--etiology
Teriparatide--administration & dosage
Urinalysis